Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma.
Myint KZ, Sueca-Comes M, Collier P, Balasubramanian B, Venkatraman S, Gordan J, Zaitoun AM, Mukherjee A, Arora A, Larbcharoensub N, Suriyonplengsaeng C, Wongprasert K, Janvilisri T, Gomez D, Grabowska AM, Tohtong R, Bates DO, Yacqub-Usman K.
Myint KZ, et al. Among authors: wongprasert k.
Front Oncol. 2023 Dec 7;13:1184900. doi: 10.3389/fonc.2023.1184900. eCollection 2023.
Front Oncol. 2023.
PMID: 38144528
Free PMC article.